Novartis Investigative Site — Nashville, Tennessee

Novartis Investigative Site is a clinical research site located in Nashville, Tennessee, United States 37215.

Crixeo Clinical Trials Trust Score: 30/100 (FAILING). This profile has not yet been claimed by the site owner.

Novartis Investigative Site has participated in 98 clinical trials with 1 currently active.

Therapeutic areas: Relapsing Multiple Sclerosis, Melanoma, Pulmonary Arterial Hypertension.

Sponsors: Novartis Pharmaceuticals, Novartis, Mylan Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 30/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novartis Investigative Site?

Novartis Investigative Site has a Crixeo Trust Score of 30/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novartis Investigative Site conducted?

Novartis Investigative Site has 98 clinical trials on record, with 1 currently active. Their work covers Relapsing Multiple Sclerosis, Melanoma, Pulmonary Arterial Hypertension.

Is Novartis Investigative Site accredited by Crixeo Clinical Trials?

Novartis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Novartis Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.